טוען...
Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients
BACKGROUND: No studies have been reported on the efficacy and safety of long-term (≥12 months) use of topical tacrolimus for refractory ocular surface inflammation in pediatric patients. METHODS: Medical records of pediatric patients who were prescribed topical 0.02% tacrolimus ointment for refracto...
שמור ב:
| הוצא לאור ב: | BMC Ophthalmol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8178927/ https://ncbi.nlm.nih.gov/pubmed/34088281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-021-01998-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|